Impact of P53 and SIRT1 in Type 2 Diabetes

ConditionDM

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age18+

SponsorSherief Abd-Elsalam

About this trial

Investigating the impact of p53 and SIRT1 in the development of type 2 DM

Eligibility criteria

Qualifiers

Prediabetic subjects.

Disqualifiers

Confirmed diabetes.

Hepatic or renal impairment.

Trial design

Treatments tested in this trial

life style
Metformin
Nigetella salivata

Treatment groups

90 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov